Literature DB >> 18312856

Cholesteroid nature of free mycolic acids from M. tuberculosis.

Yolandy Benadie1, Madrey Deysel, D Gilbert R Siko, Vanessa V Roberts, Sandra Van Wyngaardt, Simon T Thanyani, Gianna Sekanka, Annemieke M C Ten Bokum, Lynne A Collett, Johan Grooten, Mark S Baird, Jan A Verschoor.   

Abstract

Mycolic acids (MAs) are a major component of the cell walls of Mycobacterium tuberculosis and related organisms. These alpha-alkyl beta-hydroxy long fatty acids have been the subject of numerous studies for their immunological properties. We previously reported that an interaction between cholesterol and mycolic acids could be responsible for the low accuracy in the serodiagnosis of TB when using free mycolic acid in an ELISA assay. The aim of this work was to investigate if this interaction could be due to a similarity in the structural properties between mycolic acids and cholesterol. The investigation revealed that patient sera cross-reacted with mycolic acids and cholesterol in an ELISA experiment suggesting that both molecules may present related functionality in a similar structural orientation. This relation was further supported by the interaction of mycolic acids with Amphotericin B (AmB), a known binding agent to ergosterol and cholesterol. Using a resonant mirror biosensor, we observed that AmB recognised both cholesterol and mycolic acids. In addition, a specific attraction was observed between mycolic acid and cholesterol by the accumulation of cholesterol from liposomes in suspension onto immobilized mycolic acids containing liposomes, detected with a biosensor technique. Combined, these results suggest that mycolic acids can assume a three-dimensional conformation similar to a sterol. This requires that mycolic acid exposes its hydroxyl group and assumes rigidity in its chain structure to generate a hydrophobic surface topology matching that of cholesterol. A particular folded conformation would be required for this, of which a few different types have already been proven to exist in monolayers of mycolic acids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18312856     DOI: 10.1016/j.chemphyslip.2008.01.004

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  8 in total

1.  Novel phage display-derived mycolic acid-specific antibodies with potential for tuberculosis diagnosis.

Authors:  Conrad E Chan; Bryan Z Zhao; Amaury Cazenave-Gassiot; Shyue-Wei Pang; Anne K Bendt; Markus R Wenk; Paul A MacAry; Brendon J Hanson
Journal:  J Lipid Res       Date:  2013-06-24       Impact factor: 5.922

2.  Structure-function relationships of the antigenicity of mycolic acids in tuberculosis patients.

Authors:  Mervyn Beukes; Yolandy Lemmer; Madrey Deysel; Juma'a R Al Dulayymi; R Al Dulayymi Juma'a; Mark S Baird; S Baird Mark; Gani Koza; Maximiliano M Iglesias; M Iglesias Maximiliano; Richard R Rowles; R Rowles Richard; Cornelia Theunissen; Johan Grooten; Gianna Toschi; Vanessa V Roberts; V Roberts Vanessa; Lynne Pilcher; Sandra Van Wyngaardt; Nsovo Mathebula; Mohammed Balogun; Anton C Stoltz; C Stoltz Anton; Jan A Verschoor
Journal:  Chem Phys Lipids       Date:  2010-09-25       Impact factor: 3.329

Review 3.  Theory and applications of surface plasmon resonance, resonant mirror, resonant waveguide grating, and dual polarization interferometry biosensors.

Authors:  Hikmat N Daghestani; Billy W Day
Journal:  Sensors (Basel)       Date:  2010-11-01       Impact factor: 3.576

4.  The Essential Role of Cholesterol Metabolism in the Intracellular Survival of Mycobacterium leprae Is Not Coupled to Central Carbon Metabolism and Energy Production.

Authors:  Maria Angela M Marques; Marcia Berrêdo-Pinho; Thabatta L S A Rosa; Venugopal Pujari; Robertha M R Lemes; Leticia M S Lery; Carlos Adriano M Silva; Ana Carolina R Guimarães; Georgia C Atella; William H Wheat; Patrick J Brennan; Dean C Crick; John T Belisle; Maria Cristina V Pessolani
Journal:  J Bacteriol       Date:  2015-09-21       Impact factor: 3.490

5.  Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway.

Authors:  Paul Fineran; Emyr Lloyd-Evans; Nathan A Lack; Nick Platt; Lianne C Davis; Anthony J Morgan; Doris Höglinger; Raju Venkata V Tatituri; Simon Clark; Ian M Williams; Patricia Tynan; Nada Al Eisa; Evgeniya Nazarova; Ann Williams; Antony Galione; Daniel S Ory; Gurdyal S Besra; David G Russell; Michael B Brenner; Edith Sim; Frances M Platt
Journal:  Wellcome Open Res       Date:  2016-11-18

6.  New synthetic lipid antigens for rapid serological diagnosis of tuberculosis.

Authors:  Alison Jones; Mark Pitts; Juma'a R Al Dulayymi; James Gibbons; Andrew Ramsay; Delia Goletti; Christopher D Gwenin; Mark S Baird
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

7.  The antigenicity and cholesteroid nature of mycolic acids determined by recombinant chicken antibodies.

Authors:  Heena Ranchod; Fortunate Ndlandla; Yolandy Lemmer; Mervyn Beukes; Johann Niebuhr; Juma Al-Dulayymi; Susan Wemmer; Jeanni Fehrsen; Mark Baird; Jan Verschoor
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

Review 8.  Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome.

Authors:  Ynske P M van der Meer-Janssen; Josse van Galen; Joseph J Batenburg; J Bernd Helms
Journal:  Prog Lipid Res       Date:  2009-07-26       Impact factor: 16.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.